GENE ONLINE|News &
Opinion
Blog

siRNA
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Rona Therapeutics, Keymed Biosciences Team Up To Develop siRNA Drugs For Kidney Disease
2023-05-25
Sciwind Biosciences And SynerK Join Forces To Develop siRNA Therapeutics
2022-09-27
Sanofi’s siRNA Therapy Reduces Bleeds in Hemophilia, Meets Primary Endpoint
2022-07-12
Novartis Teams Up with Alnylam to Explore Targeted Liver Therapies
2022-01-07
Is the Race On for RNAi? A Chinese Pharma’s $450M Deal May Just Be the Start
2021-10-13
Scientists Successfully Use Gold-Nanoparticles to Deliver Novel Therapy for Brain Tumor
2021-03-16
Maryland Biopharma Raises $105 Million in Series D to Fund Development of RNAi Therapeutics
2020-10-24
Encouraging Performance of Cardiovascular Drug Vindicates Novartis’ $9.7 Billion Buyout Deal
2020-09-06
Alnylam’s RNAi-Based Therapy Lumasiran Impresses in Phase 3 Primary Hyperoxaluria Trials
2020-06-12
COVID-19 Antibody: Vir Biotechnology Partners with Samsung Biologics for Large Scale Manufacturing
2020-04-15
RNA-Silencing Protein AGO4 Functions In Antiviral Defense
2020-02-14
The Rejuvenated Promise of RNA Therapeutics
2020-01-07
RNA Therapeutics: An Overview
2019-12-25
Novo Nordisk Becomes Dicerna’s Fifth Big Pharma Partnership
2019-11-19
LATEST
Eli Lilly’s Tirzepatide Gets Approval in China for Weight Loss Management
2024-07-22
Roche Reports Positive Clinical Trial Results for Two Diabetes-Related Eye Disease Therapies
2024-07-19
7th Person in History Possibly Cured From HIV After Stem Cell Transplant for Acute Myeloid Leukemia
2024-07-19
Large RCT Finds Time-Lapse Imaging for Embryo Selection in IVF Does Not Improve Live Birth Rates
2024-07-19
Assessment of Supply Chain Risk Key to Improving Medicine Access
2024-07-18
SK Biopharma and Full-Life Sign US$571.5 Million Deal for Innovative Radiopharmaceutical FL-091
2024-07-18
Autoimmune Patients See Breakthrough Response to Allogeneic CD19-Targeted CAR-T Therapy
2024-07-18
EVENT
Scroll to Top